MARIETTA, Ga., Dec. 23, 2010 /PRNewswire/ — MiMedx
Group, Inc. (OTC Bulletin Board:
MDXG), an integrated developer, manufacturer and marketer of
patent protected biomaterial-based products, announced today that
it has received notification of the Class III certification for a
European product using the Company’s proprietary HydroFix™
technology.
This certification for “post surgical adhesion inhibiting
barriers” is in addition to the Company’s previous certification
for HydroFix™ Spine Shield designated as a Class IIb device
for use in certain locations along the anterior spine as a plane of
dissection during revision surgery. The new Class III certification
is for use during posterior and anterior vertebral surgeries as a
cover for the spine, including contact with the Central Nervous
System (“CNS”) and Central Circulatory System (“CCS”), to provide a
plane of dissection during revision surgery.
“As with anterior spine surgeries, where patients are exposed to
significant risks when revision surgeries are necessary, posterior
revision surgeries pose similar significant risks to the patient.
Adhesions from previous surgery can significantly interfere with
surgical technique, increase operating time and cause subsequent
complications as well,” said Parker H. “Pete” Petit, MiMedx
Chairman and Chief Executive Officer. “Posterior vertebral
surgeries are more prevalent than anterior vertebral surgeries.
With this latest certification, we can begin to market
HydroFix™ Spine Shield for use in posterior surgeries. This
will allow us to serve the demand for post-surgical adhesion
inhibiting barriers in the much broader posterior surgical
market.”
Bill Taylor, MiMedx President and Chief Operating Officer,
added, “In addition to revision surgery, the applications now
available to surgeons with this latest certification include fusion
surgery, trau
‘/>”/>
